Company intelligence / Profile preview
Guizhou Sanli Pharmaceutical
Anshun, Guizhou Province, Chinadnb.com ↗
- Ownership
- Private
- Employees
- ~2852
- Development stage
- Commercial
01
Overview
Guizhou Sanli Pharmaceutical is a commercial-stage Chinese pharmaceutical company specializing in the R&D, production, and sales of modern Chinese patent medicines. Its leading products include KaiHouJian spray for pediatric respiratory/oral conditions and Qiangli Gastrodia Elata Eucommia capsules for cardiovascular/cerebrovascular indications. The company has at least two approved drugs on the market in China.
- Therapeutic areas
- PulmonologyOtherGastroenterologyCardiovascularInfectious Diseases
- Modalities
- Herbal medicineSmall molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Guizhou Sanli Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guizhou Sanli Pharmaceutical.